Citations

Clear

157 citation(s) found for "Albert, Richard".

Impact of Atogepant on Activity Limitation in Participants With Episodic Migraine and Chronic Migraine: Post Hoc Analyses of ADVANCE, ELEVATE, and PROGRESS (P9-12.004)
Gandhi, Pranav , Dabruzzo, Brett , Umashankar, Kandavadivu , Duan, Molly, Stokes, Jonathan , Buse, Dawn C. , Lipton, Richard B. , Singh, Rashmi B. Halker , Yuan, Hsiangkuo , Gantenbein, Andreas R.

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000208534 Get It

Impact of Atogepant on Daily Functioning in Patients with Episodic Migraine and Chronic Migraine: Activity Impairment in Migraine-Diary (AIM-D) Item-Level Analysis (P12-12.004)
Lipton, Richard, Gandhi, Pranav , Buse, Dawn C. , Stokes, Jonathan , Umashankar, Kandavadivu , Dabruzzo, Brett , Duan, Molly, Lipton, Richard B. , Singh, Rashmi B. Halker , Yuan, Hsiangkuo , Gantenbein, Andreas R.

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000210708 Get It

Economic Impact of Early Vs. Late Initiation of Atogepant for The Preventive Treatment of Migraine (P10-12.007)
Lalla, Anjana, Gandhi, Pranav , Carr, Karen, Dabruzzo, Brett , Ailani, Jessica , Lalla, Anjana, Singh, Rashmi B. Halker , Lipton, Richard B.

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000208979 Get It

Characterizing Within Participant Consistency of Prodromal Symptoms in Migraine: Results from the PRODROME Trial Screening Period (P8-12.001)
Blumenfeld, Andrew , Roberts, Logan , Brand‐Schieber, Elimor , Lama, Janette Contreras‐De, Schwedt, Todd J. , Roberts, Logan, Liu, Yingyi , Lipton, Richard B.

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000208887 Get It

Interim Analysis of CONFIDENCE: A ProspeCtive ObservatioNal Study with Acute Treatment oF rImegepant ODT on ConsistENcy, SatisfaCtion and Tolerability of TrEatment in the Real World (P10-12.001)
Galabova, Boryana, Abraham, Lucy , Urani, Alexandre , Lambru, Giorgio , Lipton, Richard B. , Goadsby, Peter J. , Pozo‐Rosich, Patricia , Schwedt, Todd J. , Dai, Feng , Blakeman, Karin Hygge

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000210369 Get It

Abstract 100: Association of the Mediterranean Diet with White Matter Integrity Among Hispanics/Latinos. Final Results from the Study of Latinos-Investigation of Neurocognitive Aging-MRI (SOL-INCA-MRI) Ancillary Study
Trifan, Gabriela , Moustafa, Bayan , Lipton, Richard, Sotres‐Alvarez, Daniela , Tarraf, Wassim , Stickel, Ariana M. , Talavera, Gregory, Maillard, Pauline , DeCarli, Charles , Maillard, Pauline , Isasi, Carmen R. , Lipton, Richard B. , Cai, Jianwen , Mattei, Josiemer , Daviglus, Martha , Gonzalez, Hector M , Testai, Fernando D.

Mayo Clinic

Stroke | January 30, 2025 | Volume: 56 | Issue: Suppl_1 | Pages: No page available

10.1161/str.56.suppl_1.100 Get It

Background: High adherence to the Mediterranean Diet (MeDi) was associated with better cognitive performance and decreased memory decline among Hispanic or Latino adults. Objective: Investigate if higher adherence to the MeDi improves white matter (WM) integrity among Hispanic/Latino adults and if this effect is mediated by cardiovascular health (CVH). Methods: We included 2,774 participants from the Study of Latinos-Investigation of Neurocognitive Aging-MRI Ancillary Study. Participants completed 24-hour dietary recalls at baseline (2008-2011) which were used to calculate a MeDi score (MeDiS, range 0-9). Brain MRI and diffusion tensor images were collected between 2018 and 2022 on a 3T MRI scanner using a standardized protocol. WM integrity was ascertained using WM hyperintensity (WMH) volume and fractional anisotropy (FA). WMH volumes were residualized for total cranial volume and Ln-transformed prior to analysis. The association of MRI outcomes with MeDiS and its components was investigated using weighted linear regression analysis with complex survey design adjusting for age, sex, sociodemographic characteristics. Cardiovascular health was assessed using the Life’s Simple 7 (LS7, range 0-14) score. The mediating effect of LS7 on the primary outcome was reported as Average Causal Mediation Effects (ACME) and Average Direct Effects (ADE). Statistical significance was set at p<0.05. Results: Mean age (95% CI) at MRI scan was 64.0 (63.4 to 65.2) and 44% were males. Mean MeDiS was 5.01 (4.89 to 5.12) and LS7 was 7.1 (7.0 to 7.3). In our fully adjusted model, increasing MeDi adherence was associated with decreased LnWMH volume (β=-0.07, 95% CI -0.10 to -0.03) and increased FA (β=0.002, 95% CI 0.001 to 0.003). Increasing LS7 scores partially mediated the relationship between MeDiS and WMHs (ACME=-0.01, ADE=-0.08, p<0.05, percent mediation=9%) and between MeDiS and FA (ACME=0.0001, ADE=0.002, p<0.01, percent mediated=8%). Among the different MeDi components, consumption of whole grains and fish above sex-specific energy adjusted energy median intake predicted lower WMH volume and increase FA (p<0.05 for both). Conclusions: Among diverse Hispanic/Latino adults, high MeDi adherence was associated with preserved WM integrity. This association was partially mediated by CVH. This suggests that the beneficial effect of MeDi on brain health is not fully explained by vascular risk factors. A culturally tailored MeDi may preserve brain health among Hispanic/Latino adults.
Characterizing Prodrome (Premonitory Phase) in Migraine
Schwedt, Todd J. , Lipton, Richard B. , Goadsby, Peter J. , Chiang, Chia‐Chun , Klein, Brad , Hussar, Cory R. , Liu, Chengcheng , Yu, Sung Yun , Finnegan, M , Trugman, Joel M. , Lipton, R.B. , Klein, Brad C , Hussar, Cory , Finnegan, Michelle , Goadsby, Peter J , Chiang, Chia-Chun , Schwedt, Todd J

Mayo Clinic

Neurology Clinical Practice | October 8, 2024 | Volume: 15 | Issue: 1 | Pages: No page available

10.1212/cpj.0000000000200359 | PMID 39399572 Get It

Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome
Lipton, Richard B. , Harriott, Andrea M. , Julia, Y., Smith, Jonathan H. , Stokes, Jonathan , Gandhi, Pranav , Jariwala‐Parikh, Krutika, Jensen, G., Trugman, Joel M. , Dodick, David W. , Lipton, R.B. , Ma, Julia Y, Jensen, Gabriel S, Dodick, David W

Mayo Clinic

Neurology | August 29, 2024 | Volume: 103 | Issue: 6 | Pages: No page available

10.1212/wnl.0000000000209745 | PMID 39197113 Get It

The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group
Pradhan, Amynah , Brin, Mitchell F. , Rosen, Howard J. , Lalvani, Nim, Ashina, Messoud , Phu, Thien , Digre, Kathleen B. , Russo, Andrew F. , Buse, Dawn C. , Tassorelli, Cristina, Goadsby, Peter J., Robertson, Carrie E. , Ezzati, Ali , Pradhan, Amynah A , Charles, Andrew , Ashina, Messoud , Gelfand, Amy A , Dodick, David W , Lipton, R.B. , Robertson, Carrie E , Schwedt, Todd J. , Oshinsky, Michael L. , Charles, Andrew , Burstein, Rami , Gelfand, Amy A. , Dodick, David W. , Pozo‐Rosich, Patricia , Lipton, Richard B. , Ailani, Jessica , Szperka, Christina L. , Charleston, Larry , Powers, Scott W. , Tassorelli, Cristina

Mayo Clinic

Headache: The Journal of Head and Face Pain | August 16, 2024 | Volume: 64 | Issue: 8 | Pages: 912-930

10.1111/head.14797 | PMID 39149968 Get It

Abstract Objective To identify and disseminate research priorities for the headache field that should be areas of research focus during the next 10 years. Background Establishing research priorities helps focus and synergize the work of headache investigators, allowing them to reach the most important research goals more efficiently and completely. Methods The Headache Research Priorities organizing and executive committees and working group chairs led a multistakeholder and international group of experts to develop headache research priorities. The research priorities were developed and reviewed by clinicians, scientists, people with headache, representatives from headache organizations, health‐care industry representatives, and the public. Priorities were revised and finalized after receiving feedback from members of the research priorities working groups and after a public comment period. Results Twenty‐five research priorities across eight categories were identified: human models, animal models, pathophysiology, diagnosis and management, treatment, inequities and disparities, research workforce development, and quality of life. The priorities address research models and methods, development and optimization of outcome measures and endpoints, pain and non‐pain symptoms of primary and secondary headaches, investigations into mechanisms underlying headache attacks and chronification of headache disorders, treatment optimization, research workforce recruitment, development, expansion, and support, and inequities and disparities in the headache field. The priorities are focused enough that they help to guide headache research and broad enough that they are widely applicable to multiple headache types and various research methods. Conclusions These research priorities serve as guidance for headache investigators when planning their research studies and as benchmarks by which the headache field can measure its progress over time. These priorities will need updating as research goals are met and new priorities arise.